πŸ‡ΊπŸ‡Έ FDA
Patent

US 8790679

Intracutaneous paste composition

granted A61KA61K38/26A61K38/27

Quick answer

US patent 8790679 (Intracutaneous paste composition) held by XERIS PHARMACEUTICALS, INC. expires Mon Jul 24 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
XERIS PHARMACEUTICALS, INC.
Grant date
Tue Jul 29 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 24 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61K, A61K38/26, A61K38/27, A61K47/14, A61K47/22